ヘルプ
ヘルプ

検索結果 130 件

Improving read disturb characteristics by using double common source line and dummy switch architecture in multi level cell NAND flash memory with low power consumption (Special issue: Solid state devices and materials)

Improving read disturb characteristics by using double common source line and dummy switch architecture in multi level cell NAND flash memory with low power consumption (Special issue: Solid state devices and materials)
紙記事
Myounggon Kang, Ki-Tae Park, Youngsun Song 他<Z53-A375>Japanese journal of applied physics : JJAP50(4) (2) 2011.4p.04DD03-1～4
国立国会図書館全国の図書館

The Afghanistan papers : a secret history of the war First Simon & Schuster hardcover edition

The Afghanistan papers : a secret history of the war First Simon & Schuster hardcover edition
紙図書
Craig WhitlockSimon & Schuster2021<GE681-D4>
国立国会図書館全国の図書館

Verb doubling and dummy verb : gap avoidance strategies in verbal fronting (Linguistische Arbeiten ; volume 574)

Verb doubling and dummy verb : gap avoidance strategies in verbal fronting (Linguistische Arbeiten ; volume 574)
紙図書
Johannes HeinDe Gruyter[2020]<KE81-D40>
国立国会図書館全国の図書館

Continuous versus intermittent neuromuscular blockade in patients during targeted temperature management after resuscitation from cardiac arrest—A randomized, double blinded, double dummy, clinical trial

Continuous versus intermittent neuromuscular blockade in patients during targeted temperature management after resuscitation from cardiac arrest—A randomized, double blinded, double dummy, clinical trial
デジタル記事
2017-11Resuscitation120p.14-19
全国の図書館

Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-Blind, Double-Dummy Trial

Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-Blind, Double-Dummy Trial
デジタル記事
2020-06Clinical Gastroenterology and Hepatology18 7p.1483-1492.e2
全国の図書館

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
デジタル記事
2022-04The Lancet399 10333p.1383-1390
全国の図書館
  • 参照...l, randomised, double-blind, placebo-controlled, ph...

Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial

Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial
デジタル記事
2019-05-25Arthritis & Rheumatology71 7p.1174-1184
全国の図書館

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
デジタル記事
2021-03The Lancet397 10278p.971-984
全国の図書館
  • 参照... a randomised, double-blind, double-dummy, placebo-controlled, phase 3a...

Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial

Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
デジタル記事
2022-03The Lancet Diabetes & Endocrinology10 3p.193-206
インターネットで読める全国の図書館
  • 参照... a randomised, double-blind, double-dummy, placebo-controlled, phase 3 ...

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
デジタル記事
2018-06The Lancet Diabetes & Endocrinology6 6p.445-454
全国の図書館

Proprioceptive Focal Stimulation (Equistasi®) May Improve the Quality of Gait in Middle-Moderate Parkinson's Disease Patients. Double-Blind, Double-Dummy, Randomized, Crossover, Italian Multicentric Study

Proprioceptive Focal Stimulation (Equistasi®) May Improve the Quality of Gait in Middle-Moderate Parkinson's Disease Patients. Double-Blind, Double-Dummy, Randomized, Crossover, Italian Multicentric Study
デジタル記事
2019-09-18Frontiers in Neurology10
全国の図書館

Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
デジタル記事
2018-03The Lancet Oncology19 3p.370-381
全国の図書館

Acupuncture as prophylaxis for chronic migraine: a protocol for a single-blinded, double-dummy randomised controlled trial

Acupuncture as prophylaxis for chronic migraine: a protocol for a single-blinded, double-dummy randomised controlled trial
デジタル記事
2018-05BMJ Open8 5p.e020653-
全国の図書館
  • 要約等...ingle-blinded, double-dummy randomised controlled trial t...

A Randomized, Multicenter, Double Blind, Double Dummy Trial of Single Dose Azithromycin Versus High Dose Amoxicillin for Treatment of Uncomplicated Acute Otitis Media

A Randomized, Multicenter, Double Blind, Double Dummy Trial of Single Dose Azithromycin Versus High Dose Amoxicillin for Treatment of Uncomplicated Acute Otitis Media
デジタル記事
2005-02Pediatric Infectious Disease Journal24 2p.153-161
全国の図書館

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
デジタル記事
2018-01The Lancet391 10117p.230-240
全国の図書館

Comparison of QD and TID Oral Mesalazine for Maintenance of Remission in Quiescent Ulcerative Colitis

Comparison of QD and TID Oral Mesalazine for Maintenance of Remission in Quiescent Ulcerative Colitis
デジタル記事
2013-07Inflammatory Bowel Diseases19 8p.1681-1690
全国の図書館
  • 並列タイトル等（連結）A Double-blind, Double-dummy, Randomized Multicenter Study
  • 並列タイトル等A Double-blind, Double-dummy, Randomized Multicenter Study

Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial

Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial
デジタル記事
2017-06The Lancet389 10087p.2375-2382
全国の図書館

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial
デジタル記事
2016-07The Lancet388 10042p.343-355
全国の図書館

Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study

Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study
デジタル記事
2015-09Respiratory Medicine109 9p.1120-1125
全国の図書館

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial
デジタル記事
2016-08The Lancet Haematology3 8p.e379-e387
全国の図書館